Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4779-4796
Author(s):
S. Mocellin, P. Pilati and D. Nitti
Overview of Naphthalimide Analogs as Anticancer Agents
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4797-4813
Author(s):
Min Lv and Hui Xu
Recent Research in Selective Cyclin-Dependent Kinase 4 Inhibitors for Anti-Cancer Treatment
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4869-4888
Author(s):
Ning Liu, Hao Fang, Yanling Li and Wenfang Xu
Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy
Journal:
Current Gene Therapy
Volume:
9
Page:
434-458
Author(s):
Tranum Kaur, Roderick A. Slavcev and Shawn D. Wettig
Current Advances in Gene Therapy for the Treatment of Genodermatoses
Journal:
Current Gene Therapy
Volume:
9
Page:
487-494
Author(s):
Heather A. Long, James R. McMillan, Hongjiang Qiao, Masashi Akiyama and Hiroshi Shimizu
Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
915-930
Author(s):
Z. Yang, L. Song and C. Huang
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
938-952
Author(s):
X. Liu, R. C. Newton, S. M. Friedman and P. A. Scherle
Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
953-962
Author(s):
H. Fujihara, H. Ogino, D. Maeda, H. Shirai, T. Nozaki, N. Kamada, K. Jishage, S. Tanuma, T. Takato, T. Ochiya, T. Sugimura and M. Masutani
Antibody-Drug Conjugate Targets
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
982-1004
Author(s):
B. A. Teicher
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Journal:
Current Protein & Peptide Science
Volume:
10
Page:
585-606
Author(s):
Frederick Harris, Sarah R. Dennison and David A. Phoenix